Target To Treatment Consulting
Pauline Lukey (Director and Founder) has extensive experience as an early development leader within the pharmaceutical industry (20 years); leading all aspects of projects from target identification, through candidate selection and first dose in humans up to clinical proof of concept. Her therapeutic expertise is in tuberculosis (8 years), rheumatoid arthritis (6 years) and fibrosis (6 years). She has led both small molecule and biopharm projects through discovery and early clinical development. She has an MSc in microbiology and genetics and a PhD in immunology. She is also a honorary senior lecturer in immunology at the London School of Hygiene and Tropical Medicine.
She recently, retired from GSK and is working as a consultant to the pharmaceutical industry, biotech and academia.
See other Support/Consultancy organisations
-
Artemida Pharma is a specialist consultancy business established by a group of drug development experts, to provide strategic drug development ... -
Awridian has a proven track record with a range of groups across Drug Discovery, these include start-ups, small bio-techs, pharmaceutical ... -
Cerebro CMC supports companies involved in the development of pharmaceuticals and biopharmaceuticals. Our consultancy service is focussed on the CMC ... -
Pharmidex is a contract research organisation (CRO) providing high quality, bespoke solutions in ADME, PK, bioanalysis and toxicology. In addition, ...
Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.
Learn moreCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.